Assorted News from the Last Two Weeks: Latino children are at greater risk of developing certain cancers, and their short and long-term outcomes are often

Assorted News from the Last Week: High-Throughput drug screening of primary tumor cells identifies therapeutic strategies for treating children with high-risk cancer. Tribute to CAC2

Assorted News from the Last Week: The Senate Appropriations Committee has released its Fiscal Year 2024 Labor-HHS Appropriations bill, and we are excited to report that

Assorted News from the Last Week: A Danish study shows that five-year survival of all children with acute lymphatic leukemia (ALL) has continued to increase

Assorted News from the Last Week: From the Journal of the National Cancer Institute: “the annual rate of pediatric cancer has declined from a peak

Assorted News from the Last Week: Sub-Saharan Africa is facing a childhood cancer crisis. Annually, nearly 90% of the more than 100 000 children who develop

Assorted News from the Last Week: Yoram Unguru (past CAC2 Summit speaker, bioethicist, and uncle of a pediatric cancer survivor) on the cancer drug shortage.

Assorted News from the Last Week: NCI’s Childhood Cancer Data Initiative has grown since its launch in 2019. Read about the initiative’s activities, successes, and

Assorted News from the Last Week: The FDA’s Oncologic Drugs Advisory Committee (ODAC) met on June 16, 2023, to discuss considerations for dose optimization of

Assorted News from the Last Week: National Comprehensive Cancer Network releases statement addressing ongoing chemotherapy shortages. Childhood cancer survivors at increased risk for sleep concerns